Keyword Suggestion
Domain Informations
Coyatherapeutics.com lookup results from whois.godaddy.com server:
- Domain created: 2020-10-22T13:42:22Z
- Domain updated: 2023-01-12T17:20:01Z
- Domain expires: 2027-10-22T13:42:22Z 2 Years, 359 Days left
- Website age: 4 Years, 4 Days
- Registrar Domain ID: 2567493011_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS49.DOMAINCONTROL.COM
- NS50.DOMAINCONTROL.COM
Network
- inetnum : 35.208.0.0 - 35.247.255.255
- name : GOOGLE-CLOUD
- handle : NET-35-208-0-0-1
- status : Direct Allocation
- created : 2006-09-29
- changed : 2019-11-01
- desc : *** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,*** The IP addresses under this Org-ID are in use by Google Cloud customers ***,Direct all copyright and legal complaints to,https://support.google.com/legal/go/report,Direct all spam and abuse complaints to,https://support.google.com/code/go/gce_abuse_report,For fastest response, use the relevant forms above.,Complaints can also be sent to the GC Abuse desk,([email protected]),but may have longer turnaround times.,Complaints sent to any other POC will be ignored.
Owner
- organization : Google LLC
- handle : GOOGL-2
- address : Array,Mountain View,CA,94043,US
Abuse
- handle : GCABU-ARIN
- name : GC Abuse
- phone : +1-650-253-0000
- email : [email protected]
Technical support
- handle : ZG39-ARIN
- name : Google LLC
- phone : +1-650-253-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 35.212.110.16
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
Site Inspections
Port Scanner (IP: 35.212.110.16)
Spam Check (IP: 35.212.110.16)
Email address with coyatherapeutics.com
Recent Searched Sites
› Onehr.un.org (2 mins ago) / US
› Kevinenright.com (1 mins ago) / US
› Dijitaldunyaninenleri.com (32 seconds ago) / US
› 6-6.com.cn (1 mins ago) / TW
› Persik.id (25 seconds ago) / US
› Ilm.listedcompany.com (15 seconds ago) / US
› Coyatherapeutics.com (0 seconds ago) / US
› Der3.com (20 seconds ago) / SA
› Pa-it.deskpro.com (10 seconds ago) / US
› Awajis.com (0 seconds ago) / US
› Poppromos.com (8 seconds ago) / US
› Southernplains.org (2 mins ago) / US
› Maps.google.com.gh (5 seconds ago) / US
› Whcc.com (16 seconds ago) / US
› Skagensavis.dk (48 seconds ago) / DK
› Cfmotochile.cl (8 seconds ago) / US
› Nepalconsulate.org (5 seconds ago) / US
› Rytter-boje.technetbloggers.de (47 seconds ago) / US
› Garage456.com (8 seconds ago) / JP
› Toma-restaurant.be (1 mins ago) / FR
Websites Listing
We found Websites Listing below when search with coyatherapeutics.com on Search Engine
Home - Coya Therapeutics
Coya Therapeutics has developed a transformative ex-vivo (outside the body) platform to transform and expand billions of highly functional Tregs from millions of dysfunctional Tregs removed from a diseased patient. In addition, from the same manufacturing run, billions of highly immunosuppressive Treg derived exosomes (extracellular vesicles ...
Coyatherapeutics.comAbout Us - Coya Therapeutics
Howard Berman, Ph.D. Howard co-founded Nicoya Health in 2020 to realize the vision and research of Dr. Stanley Appel and merged the company with Coya Therapeutics in 2021 where he currently serves as Chairman and CEO. He has over 18 years of entrepreneurial and industry experience working at the interplay of science and business.
Coyatherapeutics.comCoya Therapeutics, Inc. | LinkedIn
Coya Therapeutics, Inc. 780 followers. 1w. Treatment with Coya's ALS001, a regulatory T-cell (#Treg) therapy being developed for #ALS, was found to …
Linkedin.comCoya Therapeutics | Biotech Careers
Coya Therapeutics, a clinical stage cell therapy platform company developing therapeutics for ALS and other neurodegenerative diseases. Business Areas: Cell …
Biotech.orgCoya Therapeutics, Inc. Email Formats & Employee Phones
Contact and general information about Coya Therapeutics, Inc. company, headquarter location in Houston, Texas. Email formats & phone numbers of Coya Therapeutics, Inc. …
Signalhire.comCYMABAY THERAPEUTICS
CYMABAY THERAPEUTICS. At CymaBay, we are committed to improving the lives of patients with liver and other chronic diseases by developing and providing access to innovative therapies. Our evidence-based decision making and commitment to the highest quality standards reflect our relentless dedication to the patients, families and communities we ...
Cymabay.comCoya Therapeutics, Inc. in Houston, TX | Company Info & Reviews
Coya Therapeutics, Inc. is a Texas Foreign For-Profit Corporation filed On December 15, 2020. The company's filing status is listed as In Existence and its File Number is 0803864821. The Registered Agent on file for this company is Howard Berman and is located at 12645 Memorial Drive Suite F1 #305, Houston, TX 77024.
Bizapedia.comCell therapy showing promise in ALS trials: Coya Therapeutics
2021-08-02 · Coya Therapeutics, a clinical-stage biotechnology firm that focuses on the discovery and development of treatments for neurogenerative diseases, believes it might have come upon a treatment that offers hope for ALS sufferers. Coya Therapeutics CEO Howard Berman spoke with Outsourcing-Pharma about the company’s innovative research around regulatory T-cells …
Outsourcing-pharma.comCoya Therapeutics Company Profile: Valuation & Investors
2021-02-03 · Coya Therapeutics General Information Description. Operator of a clinical-stage biotechnology company intended to develop approaches utilizing adaptive regulatory T cells to target disease. The company's technological system is patent-pending that creates an off the shelf approach to Treg cell therapy allowing for serial infusions and is focused on the …
Pitchbook.comCoya Therapeutics, Inc. - Who is raising money
2021-01-05 · Coya Therapeutics, Inc. Funding details. Coya Therapeutics, Inc. raised $10,000,000 from 57 investors on 2021-01-05. Who is raising money? CIK Number: 0001835022
Whoisraisingmoney.comCoya Therapeutics | VentureRadar
Coya Therapeutics Follow Following Location: USA. Founded in 2020 " Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal discoveries from the laboratory of Stanley Appel M.D., in which dysfunctional Tregs modulate neurodegenerative and autoimmune diseases. Coya has …
Ventureradar.comCoya Therapeutics | HTX TechList
Coya Therapeutics was founded with the purpose of acquiring, investing and developing novel therapeutics for the treatment of neurologic disorders. Read More. Read Less. TAGS therapeutics. neurology. medical-technologies. neuroscience. treatments. medical-research. Funding. Seed. Funding stage. 10M. Total raised. 1. Total rounds. 0. Investors. Seed . Jan …
Texas.globalfinder.orgCoya Therapeutics, Inc. in Wilmington, DE | Company Info & Reviews
Coya Therapeutics, Inc. is a Delaware Corporation filed On November 23, 2020. The company's filing status is listed as Active and its File Number is 4214782. The Registered Agent on file for this company is Corporation Service Company and …
Bizapedia.comCoya Therapeutics Completes Merger with Nicoya Health Inc. and ...
2021-02-03 · Coya Therapeutics leverages the innovations of Stanley H. Appel, M.D., Co-Director of Houston Methodist Neurological Institute and Chair of the Stanley H. Appel Department of Neurology at Houston Methodist Hospital. Dr. Appel is an internationally renowned researcher and neurologist, as well as one of the nation’s foremost experts on ALS treatment advances. The …
Pipelinereview.comCoya Therapeutics - Funding, Financials, Valuation & Investors
2021-02-03 · Funding. Coya Therapeutics has raised a total of $10M in funding over 1 round. This was a Series A round raised on Feb 3, 2021. Coya Therapeutics is …
Crunchbase.comHouston biotech startup announces merger and $10M series A
2021-02-03 · A Houston company has emerged from stealth mode to announce a merger and a round of financing. Coya Therapeutics, a clinical-stage biotech startup that focuses on creating therapeutics for neurodegenerative and autoimmune diseases, announced that it has completed a merger with Nicoya Health Inc. and raised $10 million in its series A.The round was led by …
Houston.innovationmap.comCoya Therapeutics | VentureRadar
Coya is developing disruptive, first in class, autologous regulatory T-cell (Treg) and allogeneic exosome therapies - leveraging the seminal... ... Find out more ...
Ventureradar.comAbout – ONK Therapeutics
This platform could be broadly applicable across a wide range of targets and tumor types, with the potential to bring significant therapeutic benefit. ONK Therapeutics is a privately held company, founded in 2015 based on the NK cell and apoptosis research of its founder Prof M O’Dwyer. MD and collaborators at National University of Ireland ...
Onktherapeutics.comLibra Therapeutics | Developing therapeutics for …
Libra Therapeutics is focused on developing novel disease-modifying therapeutics that can restore the cellular balance disrupted in neurodegenerative diseases. These include amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer's, Parkinson's, and Huntington's disease, which are all characterized by cellular disequilibrium caused by ...
Libratherapeutics.comCoya Therapeutics Announces Annals of Neurology Publication …
2022-04-27 · HOUSTON, April 27, 2022--Coya Therapeutics Announces Annals of Neurology Publication Featuring Biomarker Data in ALS Patients Treated with Tregs Cell Therapy
Ca.news.yahoo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| kotakmf.com | registrar.amazon.com | 4 Years, 270 Days |
| djbeng.com | godaddy.com | -1 Years, -145 Days |
| booking.fairbnb.coop | domains.coop | -2 Years, -264 Days |
| becare.io | onamae.com | -2 Years, -64 Days |
| skyrisetravelandtours.com | enomdomains.com | -2 Years, -105 Days |
| tiebreaker.com | godaddy.com | -2 Years, -247 Days |
| timesdirectories.com | cscdbs.com | -2 Years, -64 Days |
| getbuild.com | godaddy.com | -1 Years, -90 Days |
| subastalotes.com | webempresa.com | -1 Years, -297 Days |
| eurousa.com | networksolutions.com | 7 Years, 289 Days |